Journal article icon

Journal article

AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae

Abstract:
Objectives: AmpC β-lactamases are neglected compared with ESBL as a cause of third-generation cephalosporin (3GC) resistance in Enterobacterales in low- and middle-income countries and the burden is unknown. The aim of this study was to investigate the presence of AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical specimens from three clinical research laboratories in Southeast Asia. Methods: Stored clinical isolates of E. coli and K. pneumoniae resistant to ceftriaxone or ceftazidime or cefpodoxime and ESBL confirmation test negative were screened using MASTDISCS AmpC, ESBL and Carbapenemase Detection Set—D72C. Short-read WGS was performed to identify ampC genes. Results: Of 126 isolates collected between 2010 and 2020, 31 (24.6%) and 16 (12.7%) were phenotypically AmpC and inducible AmpC positive by MASTDISCS testing, respectively. All inducible AmpC isolates were ceftriaxone susceptible and 97.7% of AmpC/inducible AmpC isolates tested against cefoxitin were resistant. Through WGS, 17 and eight different STs were detected for the AmpC/inducible AmpC E. coli and K. pneumoniae isolates, respectively. Twelve different β-lactamase resistance genes were detected, with blaCMY-2 most commonly in AmpC-positive isolates (20/31; 64.5%; 15 chromosomal, five plasmid). All inducible AmpC-positive isolates had the blaDHA-1 gene (seven chromosomal, nine plasmid). Conclusions: Though uncommon, AmpC and inducible AmpC β-lactamases in E. coli and K. pneumoniae are an important cause of infection in Southeast Asia. With current testing methods, these infections may be going undetected, resulting in patients receiving suboptimal treatment.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1093/jacamr/dlae195

Authors


More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-8599-737X
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
https://ror.org/029chgv08


Publisher:
Oxford University Press
Journal:
JAC-Antimicrobial Resistance More from this journal
Volume:
6
Issue:
6
Article number:
dlae195
Publication date:
2024-11-28
Acceptance date:
2024-11-13
DOI:
EISSN:
2632-1823
ISSN:
2632-1823


Language:
English
Pubs id:
2067449
Local pid:
pubs:2067449
Source identifiers:
2457503
Deposit date:
2024-11-28
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP